| Literature DB >> 24760078 |
Hung-Chih Kuo1, Tsai-Ling Lauderdale2, Dan-Yuan Lo1, Chiou-Lin Chen1, Pei-Chen Chen2, Shiu-Yun Liang3, Jung-Che Kuo3, Ying-Shu Liao3, Chun-Hsing Liao3, Chi-Sen Tsao3, Chien-Shun Chiou3.
Abstract
We collected 110 Salmonella enterica isolates from sick pigs and determined their serotypes, genotypes using pulsed-field gel electrophoresis (PFGE), and antimicrobial susceptibility to 12 antimicrobials and compared the data with a collection of 18,280 isolates obtained from humans. The pig isolates fell into 12 common serovars for human salmonellosis in Taiwan; S. Typhimurium, S. Choleraesuis, S. Derby, S. Livingstone, and S. Schwarzengrund were the 5 most common serovars and accounted for a total of 84% of the collection. Of the 110 isolates, 106 (96%) were multidrug resistant (MDR) and 48 (44%) had PFGE patterns found in human isolates. S. Typhimurium, S. Choleraesuis, and S. Schwarzengrund were among the most highly resistant serovars. The majority of the 3 serovars were resistant to 8-11 of the tested antimicrobials. The isolates from pigs and humans sharing a common PFGE pattern displayed identical or very similar resistance patterns and Salmonella strains that caused severe infection in pigs were also capable of causing infections in humans. The results indicate that pigs are one of the major reservoirs to human salmonellosis in Taiwan. Almost all of the pig isolates were MDR, which highlights the necessity of strictly regulating the use of antimicrobials in the agriculture sector in Taiwan.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24760078 PMCID: PMC3997404 DOI: 10.1371/journal.pone.0095772
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Salmonella isolates from humans and pigs.
| Human | Pig | |||
| Serotype | No. isolates | No. PFGE types | No. isolates (No. shared) | No. PFGE types (No. shared) |
| Enteritidis | 5124 | 193 | ||
| Typhimurium | 4184 | 683 | 53 (13) | 20 (6) |
| Stanley | 1531 | 113 | 2 (2) | 1 (1) |
| Newport | 1254 | 228 | 3 (2) | 2 (1) |
| Albany | 722 | 172 | 5 (1) | 1 (1) |
| Agona | 645 | 94 | ||
| Paratyphi B var. Java | 547 | 113 | ||
| Weltevreden | 504 | 217 | ||
| Derby | 452 | 99 | 9 (2) | 4 (1) |
| Bareilly | 365 | 32 | ||
| Braenderup | 363 | 52 | ||
| Schwarzengrund | 325 | 115 | 7 (2) | 2 (1) |
| Virchow | 295 | 47 | ||
| Choleraesuis | 276 | 63 | 15 (7) | 7 (2) |
| Hadar | 247 | 49 | 2 (1) | 1 (1) |
| Potsdam | 146 | 42 | ||
| Mbandaka | 137 | 39 | ||
| Montevideo | 116 | 23 | ||
| Blockley | 98 | 14 | ||
| Infantis | 81 | 22 | ||
| Anatum | 80 | 25 | 3 (2) | 2 (1) |
| Itami | 62 | 10 | ||
| Typhi | 56 | 35 | ||
| Livingstone var. 14+ | 52 | 9 | 8 (8) | 2 (2) |
| London | 46 | 21 | 2 (2) | 1 (1) |
| Cerro | 41 | 7 | ||
| Litchfield | 40 | 14 | ||
| Saintpaul | 39 | 18 | ||
| IIIa 18:z4,z23:- | 30 | 2 | ||
| Kedougou | 29 | 14 | ||
| Singapore | 24 | 14 | ||
| Dublin | 23 | 4 | ||
| Isangi | 20 | 7 | ||
| Senftenberg | 19 | 17 | ||
| Brunei | 18 | 11 | 1 (1) | 1 (1) |
| Paratyphi A | 16 | 5 | ||
| Uganda | 16 | 6 | ||
| Havana | 15 | 7 | ||
| Haifa | 12 | 2 | ||
| Seremban | 12 | 4 | ||
| All 53 serotypes | 218 | 137 | ||
|
|
| 2,779 | 110 (48) | 44 (19) |
Figure 1Dendrogram constructed using the PFGE patterns of 110 Salmonella enterica isolates from pigs and the corresponding antimicrobial susceptibility patterns to the 12 indicated antimicrobials.
The dendrogram was constructed using the unweighted pair group method with an arithmetic mean algorithm. The antimicrobials shown in the sequence are cefotaxime (FTX), ceftazidime (CAZ), imipenem (IMP), nalidixic acid (NAL), ciprofloxacin (CIP), gentamicin (GEN), ampicillin (AMP), chloramphenicol (CHL), streptomycin (STR), sulfamethoxazole (SUL), tetracycline (TCY), and trimethoprim/sulfamethoxazole (SXT). “Resistance” is indicated by a red rectangle, “intermediate resistance” by a yellow rectangle, and “susceptibility” by a green rectangle. PFGE patterns shared by Salmonella isolates from human and pig are marked by blue squares. S. Typhimurium isolates are indicated with the clusters A, C, G and F, which were designated in a previous study [10].
Antimicrobial susceptibility of Salmonella isolates with common PFGE types isolated from pigs and humans.
| PFGE type | No. isolates (with AST data) | Consensus resistance pattern | FTX | CAZ | IMP | NAL | CIP | GEN | AMP | CHL | STR32 | SUL | TCY | SXT | |
| Human | Pig | ||||||||||||||
|
|
|
| |||||||||||||
| SAX.126 | 21 (10) | 5 (5) | S-S-S-R-S-S-R-R-S-R-R-R | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 100.0 (100.0) | 0.0 (0.0) | 0.0 (0.0) | 100.0 (100.0) | 100.0 (100.0) | 20.0 (0.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) |
|
|
|
| |||||||||||||
| SMX.082 | 28 (27) | 2 (2) | S-S-S-R-S-S-R-S-S-R-R-R | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 85.2 (100.0) | 0.0 (0.0) | 22.2 (100.0) | 74.1 (100.0) | 44.4 (100.0) | 40.7 (100.0) | 70.4 (100.0) | 74.1 (100.0) | 70.4 (100.0) |
|
|
|
| |||||||||||||
| SMX.418 | 6 (6) | 1 (1) | S-S-S-S-S-S-S-S-S-S-S-S | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) |
|
|
|
| |||||||||||||
| SCX.001 | 159 (157) | 6 (6) | S-S-S-R-R-R-R-R-R-R-R-R | 5.1 (83.3) | 5.6 (16.7) | 0.0 (0.0) | 97.5 (100.0) | 83.4 (100.0) | 61.1 (100.0) | 82.2 (100.0) | 83.4 (100.0) | 81.5 (50.0) | 98.1 (100.0) | 89.8 (100.0) | 77.7 (50.0) |
| SCX.044 | 6 (5) | 1 (1) | S-S-S-R-R-R-R-R-R-R-R-R | 0.0 (100.0) | 0.0 (100.0) | 0.0 (0.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) |
|
|
|
| |||||||||||||
| SDX.052 | 16 (11) | 2 (2) | S-S-S-S-S-R-R-R-R-R-R-S | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 9.1 (0.0) | 0.0 (0.0) | 72.7 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 0.0 (0.0) |
|
|
|
| |||||||||||||
| SMX.451 | 10 (7) | 2 (2) | S-S-S-S-S-S-S-S-R-S-R-S | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 14.3 (0.0) | 14.3 (0.0) | 85.7 (100.0) | 14.3 (0.0) | 85.7 (100.0) | 14.3 (0.0) |
|
|
|
| |||||||||||||
| SMX.057 | 2 (1) | 2 (2) | S-S-S-S-S-S-R-R-S-R-R-R | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 100.0 (100.0) | 100.0 (100.0) | 0.0 (0.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) |
| SMX.059 | 13 (5) | 6 (6) | S-S-S-S-S-S-R-R-S-R-R-R | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 100.0 (100.0) | 100.0 (100.0) | 0.0 (0.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) |
|
|
|
| |||||||||||||
| SMX.544 | 2 (2) | 2 (2) | S-S-S-S-S-S-R-R-S-R-R-R | 0.0 (50.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (50.0) | 0.0 (0.0) | 0.0 (50.0) | 100.0 (100.0) | 100.0 (100.0) | 0.0 (50.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) |
|
|
|
| |||||||||||||
| SNX.212 | 4 (3) | 2 (2) | S-S-S-S-S-S-S-S-S-S-S-S | 0.0 (50.0) | 0.0 (50.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (50.0) | 0.0 (50.0) | 0.0 (50.0) | 0.0 (50.0) | 0.0 (100.0) | 0.0 (50.0) | 0.0 (50.0) |
|
|
|
| |||||||||||||
| SZX.049 | 4 (4) | 2 (2) | S-S-S-R-R-R-S-R-S-R-R-R | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 100.0 (100.0) | 100.0 (100.0) | 83.3 (100.0) | 66.7 (0.0) | 100.0 (100.0) | 50.0 (0.0) | 100.0 (100.0) | 100.0 (100.0) | 83.3 (100.0) |
|
|
|
| |||||||||||||
| SLX.002 | 923 (884) | 2 (2) | S-S-S-S-S-S-R-R-S-R-R-R | 2.5 (0.0) | 2.1 (0.0) | 0.0 (0.0) | 1.0 (0.0) | 0.0 (0.0) | 0.3 (0.0) | 73.5 (100.0) | 99.0 (100.0) | 17.5 (0.0) | 99.2 (100.0) | 99.3 (100.0) | 98.5 (100.0) |
|
|
|
| |||||||||||||
| STX.001 | 1,189 (1,138) | 1 (1) | S-S-S-R-S-S-R-R-R-R-R-S | 1.1 (0.0) | 1.0 (0.0) | 0.0 (0.0) | 51.0 (100.0) | 0.0 (0.0) | 0.4 (0.0) | 97.0 (100.0) | 94.7 (100.0) | 95.1 (100.0) | 98.3 (100.0) | 96.0 (100.0) | 2.0 (0.0) |
| STX.313 | 1 (1) | 2 (2) | S-S-S-S-S-R-R-R-R-R-R-R | 100.0 (0.0) | 100.0 (0.0) | 0.0 (0.0) | 100.0 (0.0) | 0.0 (0.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (50.0) |
| STX.559 | 237 (180) | 2 (2) | S-S-S-S-S-S-R-S-R-R-R-S | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 1.1 (0.0) | 0.0 (0.0) | 0.6 (0.0) | 95.6 (100.0) | 1.1 (50.0) | 95.6 (100.0) | 95.0 (100.0) | 97.8 (100.0) | 1.1 (0.0) |
| STX.734 | 40 (2) | 2 (2) | S-S-S-S-S-S-R-S-R-R-R-S | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 100.0 (100.0) | 0.0 (0.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 0.0 (50.0) |
| STX.807 | 44 (1) | 2 (2) | S-S-S-S-S-S-R-S-R-R-R-S | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 0.0 (0.0) | 100.0 (100.0) | 0.0 (0.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 0.0 (50.0) |
| STX.863 | 1 (1) | 4 (4) | R-R-S-R-S-R-R-R-R-R-R-R | 100.0 (100.0) | 100.0 (100.0) | 0.0 (0.0) | 100.0 (100.0) | 0.0 (0.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) | 100.0 (100.0) |
| Total | 2,706 (2,445) | 110 (110) | 1.8 (25.0) | 1.6 (14.6) | 0.0 (0.0) | 32.4 (45.8) | 5.7 (18.8) | 5.3 (43.8) | 86.7 (87.5) | 87.5 (81.25) | 64.8 (52.1) | 97.5 (93.8) | 96.4 (95.8) | 43.5 (68.8) | |
The antimicrobials in the sequence (FTX-CAZ-IMP-NAL-CIP-GEN-CAMP-CHL-STR32-SUL-TCY-SXT) are cefotaxime (FTX), ceftazidime (CAZ), imipenem (IMP), nalidixic acid (NAL), ciprofloxacin (CIP), gentamicin (GEN), ampicillin (AMP), chloramphenicol (CHL), streptomycin (STR32), sulfamethoxazole (SUL), tetracycline (TCY), and trimethoprim/sulfamethoxazole (SXT). R, resistance; I, intermediate resistance; S, susceptibility.